3Hod WH. The clinical consequences of secondary hyperpar athy- roidism: focus on clinical outcomes. Nephrol Dial Transplant, 2004,19(Suppl5) .V2 - V8.
4EvenepoeI P, Claes K, Kuypers D, et al. Impact of parathyloidec- tomy on ren graft function, blood pressure and serum lipids in kidney transplant recipients a single centre study. Nephrol Dial Transplant,2005,20 (8) : 1714 - 1720.
5陈灏珠.实用内科学,第12版.北京:人民卫生出版社.2007;12;1055.
6Dlez J J, Miguel JL, Codoceo R, et al. Effects of cinacalcet on gas- trontestinal hormone release in patients with secondary hyperpar- athyroidism undergoing dialysis. Nephrol Dial Transplant, 2008, 23 (. 4) : 1387 - 1395.
5Mckane W, Chandna SM,Tattersall JE,et al. Identical decline of residual renal function in high-flux biocompatible hemodialysis and CAPD[ J]. Kidney Int,2002,61 ( 1 ) :256-265.
6Kopple JD, National Kidney Foundation K/DOQI Work Group. The National Kidney Foundation K/DOQI clinieal practice guidelines for dietary protein intake for chronic dialysis patients [ J ]. Am J Kidney Dis,2001,38(4 Suppl 1) :S68-73.
7Carofei O,Taratturfalo A,Atti S,et al. Residual renal function and post dialysis urea rebound [ J ]. EDTNA ERCA J, 1999,25 (2) :7-8.
8Termorshuizen F, Korevaar JC, Dekker FW,et al. The relative importance ofresidual renal function compared with peritoneal clearanc for patient survival and quality of life:an nanlysis of the Netherlands Cooperative Study on the Aqequacy of Dialysis (NECOS- AD ) -2 [ J ]. Am J Kidney Dis,2003,41 ( 6 ) : 1293-1 302.
9Wang AY,Woo J,Wang M ,et al. Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function [ J J. Nephrol Dial Thansplant, 2005,20 ( 2 ) : 396 -403.
10Maiorca R, Brunori C ,Zubani R,et al. Predictive value of dialysis adequacy and nutritional indices for morality and morbidity in CAPD and HD patients. A longitudinal study [ J ]. Nephrol Dial Transplant, 1995,10 ( 12 ) :2295-2305.
6Vaziri ND, Liang K. Upregulation of Acyl - CoenzymeA : Choles- terol a - eyltransferase ( ACAT ) in nephrotie syndrome. Kidney Int,2002,61 : 1769 - 1775.
7Shearer GC, Stevenson FT, Atkinson DN, et al. Hypoalbumin - emia and protein uria contribute to separately to reduced lipopro -rein catabolism in the nephrotic syndrome. Kidney Int,2001, 59(1) :179.
8Spaner DE, Miller RL, Mena J, et al. Regression of lymphomatous skin deposits in a chronic lymphocytic leukemia patient treated with the Toll like receptor -7/8 agonist, imiquimod. Leuk Lym- phoma, 2005,46 (6) :935 - 939.
9Shi YH, White D, He LW, et al. Toll - like Receptor - 7 Toleri- zes Malignant B Cells and Enhances Killing by Cytotoxic Agents. Cancer Res, 2007,67 (4) : 1823 - 1831.
10Jha P, Das BK, Shrestha S, et al. Glycemic status, lipid profile and proteinuria in diabetic nephropathy. J Nepal Med Assoc, 2010,49(178) :143 - 146.
